The Lysine Histone Methyltransferase SETD2 Is Required for Appropriate Immunoglobulin VDJ Recombination

被引：0
|
作者：
Chu, S. Haihua [1 ]
Chabon, Jonathan [2 ]
Minehart, Janna [3 ]
Matovina, Chloe N. [2 ]
Zhang, Jian [2 ]
Chen, Bo-Ruei [4 ]
Callen-Moreu, Elsa [5 ]
Hung, Putzer J. [4 ]
Feng, Zhaohui [2 ]
Koche, Richard [6 ]
Liu, X. Shirley [2 ]
Chaudhuri, Jayanta [7 ]
Nussenzweig, Andre [5 ]
Sleckman, Barry [4 ]
Armstrong, Scott A. [2 ]
机构：
[1] Dana Farber Canc Inst, Pediat Oncol, Boston, MA 02115 USA
[2] Dana Farber Canc Inst, Boston, MA 02115 USA
[3] NYU, Sch Med, New York, NY USA
[4] Weill Cornell Med Coll, New York, NY USA
[5] NCI, NIH, Bethesda, MD 20892 USA
[6] Mem Sloan Kettering Canc Ctr, Ctr Epigenet Res, 1275 York Ave, New York, NY 10021 USA
[7] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
来源：
BLOOD | 2018年 / 132卷
关键词：
D O I：
10.1182/blood-2018-99-111952
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
511
引用
收藏
页数：2
相关论文
共 50 条
  • [41] SETD2 HISTONE METHYLTRANSFERASE MUTATION STATUS PREDICTS TREATMENT RESPONSE IN GLIOBLASTOMA: STRATEGIES TO OVERCOME CHEMORESISTANCE
    Goldstein, Michael
    Gabriel, Nishanth
    Inkman, Matthew
    Zhang, Jin
    Dahiya, Sonika
    NEURO-ONCOLOGY, 2021, 23 : 81 - 81
  • [42] Histone methyltransferase SETD2 regulates osteosarcoma cell growth and chemosensitivity by suppressing Wnt/β-catenin signaling
    Jiang, Chaoying
    He, Chao
    Wu, Zhiqiang
    Li, Fengfeng
    Xiao, Jianru
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2018, 502 (03) : 382 - 388
  • [43] Canine osteosarcoma genome sequencing identifies recurrent mutations in DMD and the histone methyltransferase gene SETD2
    Heather L. Gardner
    Karthigayini Sivaprakasam
    Natalia Briones
    Victoria Zismann
    Nieves Perdigones
    Kevin Drenner
    Salvatore Facista
    Ryan Richholt
    Winnie Liang
    Jessica Aldrich
    Jeffrey M. Trent
    Peter G. Shields
    Nicholas Robinson
    Jeremy Johnson
    Susan Lana
    Peter Houghton
    Joelle Fenger
    Gwendolen Lorch
    Katherine A. Janeway
    Cheryl A. London
    William P. D. Hendricks
    Communications Biology, 2
  • [44] SETD2 Histone Methyltransferase Mutation Status Predicts Treatment Response In Glioblastoma: Strategies To Overcome Chemoresistance
    Goldstein, M.
    Gabriel, N.
    Wang, X.
    Wong, N.
    Dahiya, S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E551 - E551
  • [45] SETD2 and histone H3 lysine 36 methylation deficiency in advanced systemic mastocytosis
    G Martinelli
    M Mancini
    C De Benedittis
    M Rondoni
    C Papayannidis
    M Manfrini
    M Meggendorfer
    R Calogero
    V Guadagnuolo
    M C Fontana
    L Bavaro
    A Padella
    E Zago
    L Pagano
    R Zanotti
    L Scaffidi
    G Specchia
    F Albano
    S Merante
    C Elena
    P Savini
    D Gangemi
    P Tosi
    F Ciceri
    G Poletti
    L Riccioni
    F Morigi
    M Delledonne
    T Haferlach
    M Cavo
    P Valent
    S Soverini
    Leukemia, 2018, 32 : 139 - 148
  • [46] Methyltransferase SETD2 mediates hepatoprotection of berberine against steatosis
    Dai, Li
    Lu, Shuang
    Shen, Tianbai
    Li, Ying
    Chen, Jianjie
    ANNALS OF TRANSLATIONAL MEDICINE, 2022, 10 (10)
  • [47] Molecular basis for oncohistone 113 recognition by SETD2 methyltransferase
    Yang, Shuang
    Zheng, Xiangdong
    Lu, Chao
    Li, Guo-Min
    Allis, C. David
    Li, Haitao
    GENES & DEVELOPMENT, 2016, 30 (14) : 1611 - 1616
  • [48] SETD2 and histone H3 lysine 36 methylation deficiency in advanced systemic mastocytosis
    Martinelli, G.
    Mancini, M.
    De Benedittis, C.
    Rondoni, M.
    Papayannidis, Cristina
    Manfrini, M.
    Meggendorfer, M.
    Calogero, R.
    Guadagnuolo, V.
    Fontana, M. C.
    Bavaro, L.
    Padella, A.
    Zago, E.
    Pagano, L.
    Zanotti, R.
    Scaffidi, L.
    Specchia, G.
    Albano, F.
    Merante, S.
    Elena, C.
    Savini, P.
    Gangemi, D.
    Tosi, P.
    Ciceri, F.
    Poletti, G.
    Riccioni, L.
    Morigi, F.
    Delledonne, M.
    Haferlach, T.
    Cavo, M.
    Valent, P.
    Soverini, S.
    LEUKEMIA, 2018, 32 (01) : 139 - 148
  • [49] RAS PATHWAY MEDIATED REGULATION OF HISTONE METHYLTRANSFERASE AND TUMOR SUPPRESSOR SETD2 IN PEDIATRIC HIGH GRADE GLIOMA
    Liou, Angela
    Moran, Deborah
    Dougherty, Jacquelyn
    Harvey, Kyra
    Brosius, Stephanie
    Labella, Kay
    De Raedt, Thomas
    NEURO-ONCOLOGY, 2023, 25
  • [50] Histone methyltransferase protein SETD2 interacts with p53 and selectively regulates its downstream genes
    Xie, Ping
    Tian, Chunyan
    An, Liguo
    Nie, Jing
    Lu, Kefeng
    Xing, Guichun
    Zhang, Lingqiang
    He, Fuchu
    CELLULAR SIGNALLING, 2008, 20 (09) : 1671 - 1678
12345